首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1846026

靜脈導管市場按產品類型、材料、最終用戶和地區分類（2024-2031 年）

IV Catheters Market By Product Type (Peripheral IV Catheters Billion in, Central Venous Catheters, Midline Peripheral Catheters, Integrated/Closed IV Catheters), Material, End-User, Region for 2024-2031

出版日期: 2025年08月23日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

靜脈導管市場評估 - 2024-2031

人們對自我護理和家庭醫療保健的日益關注，推動了對方便患者在臨床環境外使用的靜脈導管的需求。隨著越來越多的患者選擇在家中進行護理和自行用藥，對方便在非臨床環境中使用的靜脈導管的需求也日益成長。因此，自我護理和家庭醫療保健的成長推動了市場規模在2024年超過89.2億美元，到2031年將達到174.9億美元。

醫院和門診手術中心手術數量的增加促進了市場擴張。輸液導管在手術期間和術後的液體、藥物和營養支持中發揮著至關重要的作用，增加了手術全期和術後護理的需求。外科手術數量的增加推動了對各種靜脈導管產品的需求，以支援整個手術過程中的病患照護。因此，預計外科手術數量的增加將推動市場在2024年至2031年間以8.78%的複合年成長率成長。

靜脈導管市場：定義/概述

靜脈 (IV) 導管是一種細長、柔軟的管子，插入靜脈後可直接將液體、藥物和血液製品輸送到血液中。它們是必不可少的醫療器械，廣泛應用於醫院、診所和居家照護等各種醫療機構，醫療設備。

靜脈導管提供了一種直接有效的治療物質輸送途徑，無需經過消化器官系統。這種方法對於那些無法經口進食或飲水，以及需要快速給藥的患者尤其有利。靜脈導管將藥物和營養物質直接輸送到血液中，從而實現精準、即時的治療效果，這對於控制急性症狀和支持持續治療至關重要。

除了在醫院和臨床環境中使用外，靜脈導管也擴大應用於家庭護理，為需要持續或間歇性治療的患者提供必要的支持。多功能且高效的靜脈治療是現代醫學的基石，有助於全面患者照護，並改善各種醫療環境中的治療效果。

醫療保健領域的快速技術進步和創新將如何推動靜脈導管市場的成長？

醫療領域的快速技術進步和創新推動了靜脈導管市場的成長。近期趨勢包括新型周邊靜脈導管、中央靜脈導管和中線周邊導管，旨在有效地將液體和藥物直接輸送到患者血液中。許多此類導管塗有緩釋藥物，有助於緩解疼痛和消炎。

中心靜脈導管市場尤其活躍，其尖端設計、材料使用和輸送機制不斷創新。供應商正在推出能夠承受高壓並與動力注射系統相容的先進針頭。這些改進旨在提高患者舒適度並最大限度地降低血液感染風險，推動市場的成長。

多腔中央靜脈導管(CVC) 的需求不斷成長，這是一個值得關注的趨勢。多腔 CVC 為需要頻繁靜脈輸液、輸血、實驗室檢查和腸外營養的患者提供了顯著的益處。它們非常受歡迎，因為它們減少了反覆插入導管的需要，並降低了感染疾病風險。供應商越來越注重開發和提供這些多腔導管，以提高效率、增加銷售量和利潤率。

技術進步也包括利用奈米技術來強化導管材料。奈米級改質可提高生物相容性並降低血栓形成風險，從而降低血栓形成的風險。此外，導管上的抗菌塗層可以抑制細菌生長，降低導管相關感染的發生率。超音波技術正被用於引導導管插入，從而提高準確性、減少併發症並提高手術成功率。這些技術創新共同推動了全球中央靜脈導管市場的成長，因為它們解決了關鍵挑戰並改善了患者預後。

由於多種因素，靜脈導管的需求預計將大幅成長。越來越多的監管機構核准靜脈導管，從而提高了市場的可靠性和可用性。包括神經系統、心血管和泌尿系統疾病在內的慢性疾病的盛行率不斷上升，推動了對這些設備的需求，尤其是在老年人口不斷成長、需要更頻繁的醫療干預的情況下。此外，人們越來越意識到預防和管理導管相關血流感染 (CRBSI) 的必要性，預計也將進一步推動需求。隨著醫護人員和患者都更加重視感染控制和提高病人安全性，預計在整個預測期內，靜脈導管的使用量將會增加。

導管血流相關的感染風險將如何阻礙靜脈導管市場的成長？

感染疾病風險，例如導管相關性血流感染 (CRBSI)，是一項重大挑戰，促使醫療機構採用嚴格的通訊協定來降低風險。然而，這些措施增加了操作複雜性和整體成本，給醫療系統和製造商都帶來了壓力。患者不適感也是一個重大問題。插入和維持留置靜脈導管會引起疼痛和不適，從而導致患者不滿。這種不適感也可能導致患者拒絕治療或停止使用，影響靜脈治療的有效性和可接受性。

產品召回也是一大風險。任何與導管品質相關的問題，例如併發症或製造缺陷，都可能導致召回。此類事件會損害製造商的聲譽，削弱市場信心，進而影響銷售和市場動態。成本壓力使情況更加複雜。先進導管技術帶來的成本上升以及持續創新的需求，可能會對製造商的定價和盈利造成巨大壓力。在成本敏感的市場中，如何在價格承受能力和技術進步之間取得平衡仍然是一項挑戰。

此外，監管障礙也構成了重大限制。嚴格的器械核准和市場准入監管要求延長了開發時間並增加了成本。滿足這些法規要求需要大量的投資和資源，這可能會延遲新產品的推出並影響整體市場的成長。

The increasing focus on self-care and home-based healthcare is driving the demand for IV catheters that are user-friendly for patients to use outside of clinical settings. As more patients manage their care and self-administer medications at home, there is a growing need for IV catheters designed for ease of use in non-clinical environments. Thus, the growth in self-care and home-based healthcare surged the growth of market size surpassing USD 8.92 Billion in 2024 to reach a valuation of USD 17.49 Billion by 2031.

The rising number of surgical procedures performed in hospitals and ambulatory surgical centers is contributing to the market's expansion. The need for IV catheters is heightened for perioperative and postoperative treatments, as they play a crucial role in administering fluids, medications, and nutrients during and after surgeries. This increase in surgical activity is driving demand for a wide range of IV catheter products to support patient care throughout the surgical process. Thus, the increasing number of surgical procedures enables the market to grow at a CAGR of 8.78% from 2024 to 2031.

IV (Intravascular) Catheter Market: Definition/ Overview

An intravenous (IV) catheter is a slender, flexible tube inserted into a vein to facilitate the direct delivery of fluids, medications, or blood products into the bloodstream. This essential medical device is widely utilized across various healthcare settings, including hospitals, clinics, and home care environments, to provide swift and effective treatment for a range of medical conditions.

IV catheters offer a direct and efficient route for administering therapeutic substances, bypassing the digestive system. This method is particularly advantageous for patients who are unable to consume food or fluids orally due to medical conditions, or when there is a need for rapid medication delivery. By ensuring that medications and nutrients are introduced directly into the bloodstream, IV catheters enable precise and immediate therapeutic effects, which is crucial for managing acute conditions and supporting ongoing treatments.

In addition to their use in hospital and clinical environments, IV catheters are increasingly employed in home care settings, where they provide vital support for patients requiring continuous or intermittent treatments. The versatility and efficiency of IV therapy make it a cornerstone of modern medical practice, facilitating comprehensive patient care and enhancing treatment outcomes across diverse healthcare scenarios.

How the Rapid Technological Advancements and Innovations in the Healthcare Sector Surge the Growth of IV Catheters Market?

Rapid technological advancements and innovations in the medical sector surge the growth of IV catheters market. Recent developments include novel peripheral IV catheters, central venous catheters, and midline peripheral catheters, which are designed to efficiently administer fluids and medications directly into the patient's bloodstream. Many of these catheters are coated with medications that are gradually released, helping to alleviate pain and reduce inflammation.

The market for central IV catheters is particularly dynamic, with ongoing innovations in tip design, material usage, and delivery mechanisms. Vendors are introducing advanced needles that can withstand high pressure and are compatible with power injectable systems. These improvements aim to enhance patient comfort and minimize the risk of bloodstream infections, driving market growth.

The rising demand for multi-lumen central venous catheters (CVCs) is a notable trend. Multi-lumen CVCs offer significant advantages for patients who require frequent intravenous medications, blood transfusions, laboratory tests, and parenteral nutrition. They reduce the need for multiple catheter insertions and lower the risk of infections, making them highly desirable. Vendors are increasingly focused on developing and offering these multi-lumen catheters to enhance efficiency and improve sales volume and profit margins.

Technological advancements also include the use of nanotechnology to enhance catheter materials. Nanoscale modifications improve biocompatibility and reduce thrombogenicity, which decreases the risk of clot formation. Additionally, integrating antimicrobial coatings on catheters helps prevent bacterial growth, reducing the incidence of catheter-related infections. Ultrasound technology is being employed to guide catheter insertion, which improves accuracy, reduces complications, and increases the success rate of procedures. These innovations collectively drive the growth of the global central IV catheter market, as they address key challenges and improve patient outcomes.

The demand for intravenous catheters is expected to rise significantly due to several factors. Increasing regulatory approvals for IV catheters are boosting market confidence and availability. The growing incidence of chronic disorders, including neurological, cardiovascular, and urological conditions, is driving the need for these devices, particularly as the elderly population continues to expand and requires more frequent medical interventions. Additionally, heightened awareness regarding the prevention and control of catheter-related bloodstream infections (CRBSI) is anticipated to further fuel demand. As both healthcare providers and patients become more focused on infection control and improving patient safety, the use of intravenous catheters is likely to increase throughout the forecast period.

How the Infection Risk Associated with the catheter bloodstream Impede the Growth of IV Catheter Market?

The risk of infection, such as catheter-related bloodstream infections (CRBSIs). These infections present significant challenges, prompting healthcare facilities to adopt stringent protocols to mitigate risks. However, these measures can increase operational complexities and overall costs, adding pressure to healthcare systems and manufacturers alike. Patient discomfort is another critical issue. The insertion and maintenance of IV catheters can cause pain and discomfort, which may lead to patient dissatisfaction. This discomfort can sometimes result in patients refusing treatment or discontinuing use, affecting the effectiveness and acceptance of IV therapy.

Product recalls pose a substantial risk as well. Any issues related to catheter quality, such as complications or manufacturing defects, can lead to recalls. Such incidents damage the reputation of manufacturers and undermine market confidence, potentially impacting sales and market dynamics. Cost pressures further complicate the landscape. The rising costs associated with advanced catheter technologies and the need for continual innovation can exert significant pressure on pricing and profitability for manufacturers. Balancing affordability with technological advancements remains a challenge in a cost-sensitive market.

Additionally, regulatory hurdles are a considerable restraint. The stringent regulatory requirements for device approval and market entry can extend development timelines and increase costs. Navigating these regulations requires substantial investment and resources, which can delay the introduction of new products and impact overall market growth.

Category-Wise Acumens

How the Low-Cost Therapy and Highly Favored Clinical Settings Surge the Growth of the Peripheral IV Catheter Segment?

The peripheral IV catheter segment significantly dominates the IV catheter market. Peripheral intravenous catheters (PIVCs) are increasingly favored in clinical settings for their ease of installation and removal, offering a more comfortable and minimally invasive option for obtaining intravenous therapy. This approach enhances patient satisfaction and proves to be more cost-effective compared to midline peripheral catheters and central venous catheters. The low cost of PIVCs, coupled with their user-friendly nature, positions them as a popular choice in various medical procedures.

The market for PIVCs is expected to experience growth driven by strategic initiatives from industry players, such as the introduction of innovative products, strategic partnerships, and mergers and acquisitions. This peripheral catheter significantly reduces the risk of needle stick injuries and blood exposure, contributing to safer intravenous access for healthcare providers.

Furthermore, the increasing preference for minimally invasive procedures is fueling the demand for PIVCs. These procedures are associated with shorter recovery times, reduced discomfort, and lower risk of complications, making them appealing for both patients and healthcare practitioners. PIVCs are commonly used to administer anesthetics and medications during such procedures, underscoring their importance in modern medical practices. As the adoption of minimally invasive techniques continues to rise, the demand for PIVCs is expected to grow, driven by their practical benefits and the ongoing evolution of medical technologies.

How do the Increasing Medical Procedures and Escalating Hospitalization Rates Foster the Growth Hospitals Pharmacies Segment?

The Hospital Pharmacies segment significantly dominates the IV Catheter Market. The global increase in hospitalization rates and the growing volume of medical procedures requiring IV fluid and solution infusion are major drivers of the IV catheter market. Hospitals remain the primary setting for IV catheter use, accounting for the majority of sales and continuing to dominate the market.

In these healthcare facilities, hospital pharmacies and stores play a crucial role in the distribution and storage of pharmaceuticals, including IV catheters. These on-site pharmacies manage a broad range of medications, from standard treatments to specialized and experimental drugs. As hospitals prioritize patient safety, there is a significant focus on minimizing the risks associated with IV catheter use, such as infections and complications.

In addition, to these concerns, hospitals are increasingly demanding IV catheters that feature advanced safety features. For instance, IV catheters with antimicrobial coatings are sought after for their ability to reduce infection risks, while needleless connectors are preferred for their role in minimizing needle-stick injuries and enhancing overall safety. This trend highlights the hospital's commitment to improving patient outcomes and safety through the adoption of more sophisticated and safer catheter technologies.

Gain Access to IV (Intravascular) Catheter Market Report Methodology

Country/Region-wise Acumens

How do the Increasing Geriatric Population and the Extensive Network of Hospitals in the Region Surge the Growth of the IV (Intravascular) Catheter Market?

North America substantially dominates the IV (Intravascular) catheter market. The increasing prevalence of chronic disorders and the rising geriatric population contribute to a higher demand for IV catheters, driven further by the presence of leading manufacturers such as Boston Scientific Corporation, BD, and Teleflex Incorporated. These companies are positively impacting regional market growth through their innovations and market activities. The extensive network of hospitals, clinics, and ambulatory care centers worldwide creates a substantial and consistent demand for IV catheters. The broad availability of these healthcare facilities ensures that a large patient base, requiring intravenous treatments for various conditions, has reliable access to essential catheter devices. The increasing global elderly population is particularly susceptible to chronic diseases that often necessitate prolonged or frequent IV therapy. As the number of aging individuals rises, so does the need for IV catheters to manage age-related health issues effectively and provide ongoing medical care.

Favorable government policies, heightened public awareness, and the presence of highly qualified medical professionals and renowned healthcare facilities further bolster the market's expansion in North America. The high incidence of chronic diseases is anticipated to increase hospital admissions, which in turn will drive demand for vascular catheterization and vein access treatments. Innovations such as advanced biocompatible materials, antimicrobial coatings, and user-friendly designs are improving patient outcomes and driving market growth. These advancements contribute to safer, more effective catheterization processes, benefiting patients and healthcare providers.

Additionally, strategic initiatives by market players, including product innovations and various other activities, are contributing to the region's market growth. North America is expected to hold the largest share of the intravascular catheters market during the forecast period, largely due to the increasing incidence of renal diseases. The increasing emphasis on reducing healthcare-associated infections (HAIs) and improving patient safety. This focus has led to the development and adoption of advanced IV catheters equipped with features such as needleless connectors and antimicrobial coatings. Stringent regulations and guidelines surrounding infection control are propelling the market for these advanced safety-oriented products.

How the Increasing Investments in the Healthcare Sector and Growing Incidence of Chronic Conditions Foster the Growth of IV (Intravascular) Catheter Market?Bottom of Form

Investments in expanding and upgrading healthcare facilities fueling strong demand for medical devices, including IV catheters. The establishment of new hospitals, clinics, and specialized care centers, along with the enhancement of existing infrastructure, ensures that a wide array of medical devices, including IV catheters, are required to support advanced patient care. The growing incidence of chronic conditions such as diabetes, cancer, and cardiovascular diseases is driving a heightened need for long-term IV therapy. As these diseases become more prevalent, the demand for IV catheters increases, given their essential role in the ongoing management and treatment of these conditions. In countries like Japan and South Korea, the rapidly aging population is leading to a greater need for IV catheters. Older adults are more prone to chronic illnesses and age-related health issues that often require intravenous treatment. This demographic shift is substantially driving the demand for IV catheters to address the specific needs of the elderly.

Increasing disposable incomes are enhancing access to healthcare services and advanced medical treatments. As individuals' financial capabilities improve, they are more likely to seek high-quality medical care and invest in advanced medical technologies, including IV catheters. This rise in disposable income contributing to the broader adoption of these medical devices. Government support for healthcare infrastructure development and a strong emphasis on patient safety are pivotal in driving market growth. Various government initiatives aim to improve healthcare access, implement rigorous infection control measures, and promote the use of advanced medical devices. These efforts are supporting the expansion of the IV catheter market by fostering a safer and more efficient healthcare environment.

Competitive Landscape

The IV (Intravascular) catheter market is characterized by a mix of established global players and regional manufacturers. The industry is highly competitive, with companies focused on product innovation, cost-efficiency, and strong distribution networks.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the IV (Intravascular) catheter market include:

BD (Becton, Dickinson, and Company)
Braun Melsungen AG
ICU Medical, Inc.
Teleflex Incorporated
Terumo Corporation
Smiths Medical
Medtronic
Abbott Laboratories
Edwards Lifesciences Corporation
Coloplast A/S
Stryker Corporation
Cook Medical
Merit Medical Systems, Inc.
Vygon
Nipro Corporation
Medsource Labs

Latest Developments:

In October 2023, Linear Health Sciences announced that the Orchid SRV safety release valve had achieved US FDA approval. The device was approved for use with all IV access procedures; the catheter was designed to reduce the likelihood of IV catheter failure and repair in hospitals.
In April 2023, BD announced the Prevue II System, a completely innovative, user-friendly sophisticated ultrasound system with a tailored probe designed to assist surgeons in accurately implanting intravenous placements.
In September 2022, B. Braun SE announced the acquisition of Starboard Medical, Inc.'s cutting-edge Clik-FIX catheter protection device portfolio. With this acquisition, B. Braun added to its track record of creating new products and programs that improve patient outcomes and experiences with peripheral intravenous (IV) therapy.
In January 2022, ICU Medical, Inc. Smiths Medical announced the acquisition of Smiths Group plc. Smith's Medical specializes in syringe and mobile infusion devices, vascular access, and critical care solutions.